Áîëåçíè ñêëåðû, ðîãîâèöû, ðàäóæíîé îáîëî÷êè è öèëèàðíîãî òåëà (H15-H22)
Áîëåçíè ñêëåðû
Ñêëåðèò
ÄÅÊÑÀÌÅÒÀÇÎÍWARSAW PHARMACEUTICAL WORK POLFA
ÄÅÊÑÀÏÎÑURSAPHARM ARZNEIMITTEL GmbH & Co KG
ÏÅÔËÎÊÑÀÖÈÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
Êåðàòèò
ÀÊÒÎÂÅÃÈÍNYCOMED AUSTRIA GmbH
ÄÅÊÑÀ-ÃÅÍÒÀÌÈÖÈÍURSAPHARM ARZNEIMITTEL GmbH & Co KG
ÄÅÊÑÀÌÅÒÀÇÎÍWARSAW PHARMACEUTICAL WORK POLFA
ÄÅÊÑÀÏÎÑURSAPHARM ARZNEIMITTEL GmbH & Co KG
ÊÎÐÍÅÐÅÃÅËÜDr. MANN PHARMA GmbH
ÍÎÐÌÀÊÑIPCA LABORATORIES Ltd.
ÎÐÓÍÃÀÌÈÍÎÇÎÍ ÎÎÎ
ÎÐÓÍÈÒÔÏ ÎÁÎËÅÍÑÊÎÅ ÇÀÎ
ÔËÎÊÑÀËDr. MANN PHARMA GmbH
ßçâà ðîãîâèöû
ÀÊÒÎÂÅÃÈÍNYCOMED AUSTRIA GmbH
ÊÎÐÍÅÐÅÃÅËÜDr. MANN PHARMA GmbH
ÍÎÐÌÀÊÑIPCA LABORATORIES Ltd.
ÔËÎÊÑÀËDr. MANN PHARMA GmbH
ÖÈÏÐÎÔËÎÊÑÀÖÈÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
Êåðàòîêîíúþíêòèâèò
ÄÅÊÑÀÌÅÒÀÇÎÍWARSAW PHARMACEUTICAL WORK POLFA
ÄÅÊÑÀÏÎÑURSAPHARM ARZNEIMITTEL GmbH & Co KG
ÄÅÐÈÍÀÒÒÅÕÍÎÌÅÄÑÅÐÂÈÑ ÇÀÎ ÔÏ
ÍÎÐÌÀÊÑIPCA LABORATORIES Ltd.
ÏÅÔËÎÊÑÀÖÈÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
ÖÈÏÐÎÔËÎÊÑÀÖÈÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
Íåîâàñêóëÿðèçàöèÿ ðîãîâèöû
ÃÈÄÐÎÊÎÐÒÈÇÎÍ-ÏÎÑ NURSAPHARM ARZNEIMITTEL GmbH & Co KG
Äðóãèå áîëåçíè ðîãîâèöû
Íàñëåäñòâåííûå äèñòðîôèè ðîãîâèöû
ÊÎÐÍÅÐÅÃÅËÜDr. MANN PHARMA GmbH
Ïîðàæåíèÿ ñêëåðû è ðîãîâèöû ïðè áîëåçíÿõ, êëàññèôèöèðîâàííûõ â äðóãèõ ðóáðèêàõ
Èðèäîöèêëèò
ÄÅÊÑÀÌÅÒÀÇÎÍWARSAW PHARMACEUTICAL WORK POLFA
Îñòðûé è ïîäîñòðûé èðèäîöèêëèò (ïåðåäíèé óâåèò)
ÃÈÄÐÎÊÎÐÒÈÇÎÍ-ÏÎÑ NURSAPHARM ARZNEIMITTEL GmbH & Co KG
ÄÅÊÑÀÏÎÑURSAPHARM ARZNEIMITTEL GmbH & Co KG
ÐÅÎÏÎËÈÃËÞÊÈÍ Ñ ÃËÞÊÎÇÎÉÁÈÎÕÈÌÈÊ ÎÀÎ
ÐÅÎÏÎËÈÄÅÊÑ®ÁÈÎÑÈÍÒÅÇ ÎÀÎ
Èðèäîöèêëèò, âûçâàííûé ëèíçàìè
ÀÊÒÎÂÅÃÈÍNYCOMED AUSTRIA GmbH
ÁÅÒÀÄÐÈÍWARSAW PHARMACEUTICAL WORK POLFA
ÊÎÐÍÅÐÅÃÅËÜDr. MANN PHARMA GmbH
ÝÌÎÊÑÈÏÈÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ
Äðóãèå áîëåçíè ðàäóæíîé îáîëî÷êè è öèëèàðíîãî òåëà
Ãèôåìà
ÝÌÎÊÑÈÏÈÍ-ÀÊÎÑÑÈÍÒÅÇ ÎÀÎ